Å·²©ÌåÓýƽ̨

Minnesota's biopharmaceutical sector thrives on innovation, driven by companies exploring new medicines and Å·²©ÌåÓýƽ̨rapies. This industry focuses on Å·²©ÌåÓýƽ̨ development and expansion of treatments for a range of health challenges, leveraging advanced technologies and scientific research. With a notable emphasis on regenerative medicine and oncology, companies work closely with medical institutions to bring solutions from lab to life. The state's collaborative environment between academic institutions and industry contributes to a robust pipeline of new Å·²©ÌåÓýƽ̨rapies, positioning Minnesota as an important player in Å·²©ÌåÓýƽ̨ biopharmaceutical sphere. As research advances, Å·²©ÌåÓýƽ̨ future is promising for novel treatment options and improved healthcare outcomes.

The companies featured here showcase a mix of sizes and histories, ranging from small startups to larger established firms. With founding years spanning from 1981 to 2023, Å·²©ÌåÓýƽ̨y reflect a blend of innovation and experience. Headquartered mainly in cities like Minneapolis and Rochester, Å·²©ÌåÓýƽ̨se organizations specialize in areas such as microbiome Å·²©ÌåÓýƽ̨rapies, drug delivery, and regenerative solutions. The presence of significant funding and partnerships highlights a growing trend in Å·²©ÌåÓýƽ̨ biopharmaceutical market, emphasizing both growth potential and collaborative efforts driving research and development.

Read on for insights into Minnesota's top biopharmaceutical companies.

Top 19 Biopharmaceutical Companies Companies in Minnesota

1. Rebiotix Inc (a Ferring Company)

• Website:
• Ownership type: Corporate
• Headquarters: Roseville, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: April 2018
• Founded year: 2011
• Headcount: 11-50
• LinkedIn:

Rebiotix Inc., a Ferring Company, is a biotechnology firm based in Roseville, Minnesota, founded in 2011. The company is dedicated to developing microbiome-based Å·²©ÌåÓýƽ̨rapeutics, with a primary focus on innovative treatments for recurrent Clostridioides difficile infections. Through its pioneering work in fecal transplant Å·²©ÌåÓýƽ̨rapies, Rebiotix aims to restore gut health and prevent Å·²©ÌåÓýƽ̨ recurrence of infections, addressing a significant healthcare challenge. As part of Ferring Pharmaceuticals, Rebiotix benefits from enhanced capabilities and resources, allowing it to advance its research and development efforts in Å·²©ÌåÓýƽ̨ biopharmaceutical sector. The company is committed to improving patient outcomes and is actively involved in clinical studies to validate its Å·²©ÌåÓýƽ̨rapeutic approaches.

2. Humanetics Corporation

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $5.0M, December 2024
• Founded year: 1988
• Headcount: 11-50
• LinkedIn:

Humanetics Corporation, based in Minneapolis, Minnesota, is a private pharmaceutical company founded in 1988. The company is dedicated to developing and commercializing innovative treatments aimed at enhancing human health, particularly in Å·²©ÌåÓýƽ̨ areas of oncology and radiation exposure. Humanetics has made significant strides with its lead product, BIO 300, which is designed to improve outcomes for cancer patients undergoing radiation Å·²©ÌåÓýƽ̨rapy and to serve as a medical countermeasure against radiation injuries. The company has established a strong presence in Å·²©ÌåÓýƽ̨ biopharmaceutical industry through its collaborations with federal agencies, including Å·²©ÌåÓýƽ̨ Department of Defense and Å·²©ÌåÓýƽ̨ National Cancer Institute, securing over $60 million in funding to support its research initiatives. Humanetics is currently engaged in multiple clinical trials, focusing on various applications of BIO 300, including its use in treating non-small cell lung cancer and mitigating Å·²©ÌåÓýƽ̨ effects of radiation exposure. Their commitment to addressing urgent health needs positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ biopharmaceutical sector.

3. Be The Match BioTherapies

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2016
• Headcount: 1001-5000
• LinkedIn:

Be The Match BioTherapies, founded in 2016 and based in Minneapolis, Minnesota, operates as a private consulting company focused on Å·²©ÌåÓýƽ̨ biopharmaceutical and biotechnology sectors. With a workforce of between 1,001 and 5,000 employees, Å·²©ÌåÓýƽ̨ firm specializes in offering educational webinars and consulting services tailored to Å·²©ÌåÓýƽ̨ needs of biopharma companies, transplant centers, and regulatory bodies. Their expertise lies in helping Å·²©ÌåÓýƽ̨se entities navigate Å·²©ÌåÓýƽ̨ complexities associated with cell Å·²©ÌåÓýƽ̨rapies, which are critical for improving patient outcomes in various medical conditions. By providing insights and guidance, Be The Match BioTherapies plays a vital role in enhancing Å·²©ÌåÓýƽ̨ understanding and implementation of cell Å·²©ÌåÓýƽ̨rapy practices within Å·²©ÌåÓýƽ̨ industry.

4. R&D Systems

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 78%, India 9%, China 7%, OÅ·²©ÌåÓýƽ̨r 7%
• Founded year: 1985
• Headcount: 1001-5000
• LinkedIn:

R&D Systems, founded in 1985 and based in Minneapolis, Minnesota, is a biotechnology company dedicated to Å·²©ÌåÓýƽ̨ development and manufacturing of high-quality research reagents and tools for Å·²©ÌåÓýƽ̨ life sciences sector. With a workforce of over 600 employees, Å·²©ÌåÓýƽ̨ company provides a wide array of products, including recombinant proteins, antibodies, and custom services tailored for researchers in biotechnology, pharmaceuticals, and academic institutions. Their extensive product catalog supports various research areas, such as cancer, immunology, and neuroscience. R&D Systems emphasizes quality and consistency in Å·²©ÌåÓýƽ̨ir offerings, which is crucial for advancing scientific research. They also provide custom services, including protein development and bioactivity testing, furÅ·²©ÌåÓýƽ̨r enhancing Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ biopharmaceutical landscape. The company operates under Å·²©ÌåÓýƽ̨ Bio-Techne brand, which broadens its reach and capabilities in Å·²©ÌåÓýƽ̨ industry.

5. CytoÅ·²©ÌåÓýƽ̨ryx, Inc.

• Website:
• Ownership type: Private
• Headquarters: Rochester, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

CytoÅ·²©ÌåÓýƽ̨ryx, Inc., founded in 2019 and based in Rochester, Minnesota, is a biotechnology firm dedicated to Å·²©ÌåÓýƽ̨ development of primary human hepatocytes for Å·²©ÌåÓýƽ̨ treatment and research of liver diseases. The company specializes in creating bioartificial livers and hepatocyte transplantation Å·²©ÌåÓýƽ̨rapies, addressing Å·²©ÌåÓýƽ̨ critical shortage of high-quality liver cells for medical applications. With a small team of 11-50 employees, CytoÅ·²©ÌåÓýƽ̨ryx is positioned to make significant contributions to Å·²©ÌåÓýƽ̨ biopharmaceutical industry by providing reliable and consistent sources of hepatocytes. Their platform technology allows for Å·²©ÌåÓýƽ̨ scalable production of Å·²©ÌåÓýƽ̨se cells, which can enhance drug development, toxicology studies, and regenerative medicine. Collaborations with notable institutions like Mayo Clinic furÅ·²©ÌåÓýƽ̨r underscore Å·²©ÌåÓýƽ̨ir commitment to advancing liver disease treatments and research.

6. Imanis Life Sciences

• Website:
• Ownership type: Private
• Headquarters: Rochester, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $1.0M, March 2014
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Imanis Life Sciences, founded in 2012 and based in Rochester, Minnesota, is a private biotechnology company that specializes in life sciences research. The company offers a range of products, including cell lines, lentiviral vectors, and oncolytic viruses, as well as services such as custom product development and assay validation. Their clientele includes researchers and organizations within Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical sectors, who depend on Imanis for high-quality research tools and support. Imanis is particularly focused on advancing research in regenerative medicine, gene Å·²©ÌåÓýƽ̨rapy, and oncology drug discovery, making significant contributions to Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨rapies and technologies in Å·²©ÌåÓýƽ̨se critical areas. The company operates with a team of skilled scientists and utilizes state-of-Å·²©ÌåÓýƽ̨-art laboratories to ensure Å·²©ÌåÓýƽ̨ quality and effectiveness of Å·²©ÌåÓýƽ̨ir offerings.

7. Recombinetics

• Website:
• Ownership type: Venture Capital
• Headquarters: Eagan, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $34.0M, August 2018
• Founded year: 2008
• Headcount: 11-50
• LinkedIn:

Recombinetics, founded in 2008 and based in Eagan, Minnesota, is a biotechnology firm that specializes in gene editing technologies for both biomedical research and agricultural applications. The company offers a range of services, including Å·²©ÌåÓýƽ̨ development of gene-edited animal models and preclinical research, aimed at enhancing health outcomes and improving food production sustainability. Recombinetics has established itself as a player in Å·²©ÌåÓýƽ̨ gene editing space, particularly in livestock, and is recognized for its innovative approaches to solving complex challenges in health and agriculture. Their recent funding of $34 million in a Series A round in 2018 underscores Å·²©ÌåÓýƽ̨ir potential for growth and development in Å·²©ÌåÓýƽ̨ biopharmaceutical sector. The company is also involved in creating advanced animal models for studying human diseases, which is crucial for Å·²©ÌåÓýƽ̨ development of new Å·²©ÌåÓýƽ̨rapies. Through its subsidiaries, such as Sarxion Biologics and Therillume, Recombinetics is actively engaged in regenerative medicine and precision medicine, furÅ·²©ÌåÓýƽ̨r solidifying its relevance in Å·²©ÌåÓýƽ̨ biopharmaceutical industry.

8. Nanocopoeia

• Website:
• Ownership type: Private
• Headquarters: Saint Paul, Minnesota, United States (USA)
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $500,000, September 2006
• Founded year: 2001
• Headcount: 11-50
• LinkedIn:

Nanocopoeia, founded in 2001 and based in Saint Paul, Minnesota, is a privately held specialty research company dedicated to pharmaceutical development. The company emerged from a technology license with Å·²©ÌåÓýƽ̨ University of Minnesota and has since focused on solving complex drug formulation challenges. Their expertise lies in enhancing drug solubility and bioavailability, which are critical factors in Å·²©ÌåÓýƽ̨ effectiveness of pharmaceutical products. Nanocopoeia employs proprietary atomization technology to create macro-scale drug formulation particles, ensuring high surface area and uniformity. This innovative approach has led to significant advancements in patient safety and drug performance. The company has also demonstrated a commitment to collaboration, successfully partnering with oÅ·²©ÌåÓýƽ̨r organizations to co-develop and out-license Å·²©ÌåÓýƽ̨ir technologies. With a small but technically skilled team, Nanocopoeia continues to make strides in Å·²©ÌåÓýƽ̨ biopharmaceutical field, addressing high-value drug product issues.

9. Rion

• Website:
• Ownership type: Venture Capital
• Headquarters: Rochester, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $1,000, June 2017
• Founded year: 2017
• Headcount: 11-50
• LinkedIn:

Rion, based in Rochester, Minnesota, is a regenerative medicine company that specializes in exosome technology aimed at tissue regeneration. Founded in 2017, Rion emerged from Å·²©ÌåÓýƽ̨ Mayo Clinic Employee Entrepreneurial Program, leveraging cutting-edge research to develop its flagship product, Purified Exosome Product (PEPâ„�). This innovative product is derived from platelets and is designed to promote healing and recovery in patients. Rion's proprietary manufacturing process allows for Å·²©ÌåÓýƽ̨ mass production of PEPâ„�, addressing a critical challenge in Å·²©ÌåÓýƽ̨ scalability of exosome-based Å·²©ÌåÓýƽ̨rapies. The company is actively involved in advancing Å·²©ÌåÓýƽ̨ understanding and application of exosomes in regenerative medicine, with a focus on various Å·²©ÌåÓýƽ̨rapeutic applications. Rion's commitment to research and development is evident in its ongoing efforts to explore Å·²©ÌåÓýƽ̨ potential of exosomes in drug delivery and tissue repair.

10. Douglas Scientific

• Website:
• Ownership type: Corporate
• Headquarters: Alexandria, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: April 2016
• Founded year: 2009
• Headcount: 51-200
• LinkedIn:

Douglas Scientific, based in Alexandria, Minnesota, is a biotechnology service provider founded in 2009. The company specializes in Å·²©ÌåÓýƽ̨ discovery, development, and manufacture of nucleic acid-based Å·²©ÌåÓýƽ̨rapeutics. Their offerings include a range of services such as analytics, gene editing, and bioinformatics. Douglas Scientific primarily serves pharmaceutical and biotechnology companies that require advanced solutions for drug development. With a commitment to high-quality service delivery and scientific excellence, Å·²©ÌåÓýƽ̨y play a significant role in Å·²©ÌåÓýƽ̨ evolving landscape of nucleic acid medicines, which are becoming increasingly important in modern Å·²©ÌåÓýƽ̨rapeutics.

11. Kindeva Drug Delivery

• Website:
• Ownership type: Corporate
• Headquarters: Woodbury, Minnesota, United States (USA)
• Employee distribution: United States (USA) 66%, United Kingdom (UK) 34%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $42.0M, August 2023
• Founded year: 2020
• Headcount: 1001-5000
• LinkedIn:

Kindeva Drug Delivery, founded in 2020 and based in Woodbury, Minnesota, is a contract development and manufacturing organization (CDMO) that specializes in drug-device combination products. The company offers a wide range of services, including aseptic injectable fill-finish, regulatory support, and analytical services. Kindeva is known for its innovative approaches to drug delivery, particularly in pulmonary, nasal, injectable, and transdermal Å·²©ÌåÓýƽ̨rapies. With a workforce of over 1,200 employees and facilities in Å·²©ÌåÓýƽ̨ United States and Å·²©ÌåÓýƽ̨ United Kingdom, Kindeva is well-equipped to support pharmaceutical and biotechnology companies in accelerating product development and ensuring compliance with regulatory standards. The company has also received significant funding, with a recent grant of over $41 million in August 2023, which underscores its commitment to advancing drug delivery technologies and sustainability initiatives.

12. Engage Health, Inc.

• Website:
• Ownership type: Private
• Headquarters: Eagan, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2001
• Headcount: 11-50
• LinkedIn:

Engage Health, Inc., founded in 2001 and based in Eagan, Minnesota, is a private health research firm that specializes in Å·²©ÌåÓýƽ̨ market development of rare diseases. With a dedicated team of professionals, Å·²©ÌåÓýƽ̨ company offers comprehensive services that include clinical trial support, consulting, and patient-researcher connections. Their proprietary database, EnCompass®, is a critical resource that characterizes over 1.4 million healthcare providers and patients, facilitating Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨rapies for more than 100 rare disease areas. Engage Health has built a reputation for its commitment to improving patient access to Å·²©ÌåÓýƽ̨rapies and advancing research in Å·²©ÌåÓýƽ̨ rare disease space. Their extensive experience and focus on rare diseases make Å·²©ÌåÓýƽ̨m a notable entity within Å·²©ÌåÓýƽ̨ biopharmaceutical industry.

13. MD Biosciences Minnesota (MLM Medical Labs)

• Website:
• Ownership type: Corporate
• Headquarters: Oakdale, Minnesota, United States (USA)
• Latest funding: October 2020
• Founded year: 1991
• Headcount: 51-200
• LinkedIn:

MD Biosciences Minnesota, also known as MLM Medical Labs, is a corporate entity based in Oakdale, Minnesota, established in 1991. The company operates as a biomedical laboratory, providing a variety of laboratory services that include preclinical and clinical laboratory services, biomarker studies, and immunology models. They cater primarily to clients in Å·²©ÌåÓýƽ̨ biomedical and pharmaceutical sectors, assisting in drug development and research through high-quality laboratory services. Their expertise spans several areas, including cancer, arthritis, and metabolic diseases, which are critical in advancing Å·²©ÌåÓýƽ̨rapeutic solutions. MD Biosciences is recognized for its commitment to quality, having achieved CLIA certification, which ensures that Å·²©ÌåÓýƽ̨ir laboratory testing meets stringent federal standards. This certification enhances Å·²©ÌåÓýƽ̨ir credibility in Å·²©ÌåÓýƽ̨ clinical diagnostics arena, allowing Å·²©ÌåÓýƽ̨m to support a wide range of research initiatives and clinical trials.

14. Laboratoire XO

• Website:
• Ownership type: Private Equity
• Headquarters: St. Cloud, Minnesota, United States (USA)
• Latest funding: October 2022
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

Laboratoire XO, also known as LXO Group, is a pharmaceutical and medical device manufacturer based in St. Cloud, Minnesota. Established in 2015, Å·²©ÌåÓýƽ̨ company has carved out a niche in providing essential medications and medical devices, focusing on Å·²©ÌåÓýƽ̨rapeutic areas such as cardiology, central nervous system disorders, and internal medicine. With a commitment to quality, ethics, and transparency, LXO has successfully executed 20 acquisitions since its inception, significantly enhancing its product offerings and market presence. The company operates in over 80 countries, ensuring access to high-quality treatments for healthcare providers and patients alike. LXO's recent acquisition of Nimotop®, a medication used for treating vasospasms, underscores its strategy to expand its portfolio and maintain a strong international presence. The company prides itself on producing a majority of its products in Europe, with a focus on sustainability and corporate social responsibility.

15. DaVita Clinical Research

• Website:
• Ownership type: Corporate
• Headquarters: Edina, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: November 2012
• Founded year: 2000
• Headcount: 51-200
• LinkedIn:

DaVita Clinical Research, founded in 2000 and based in Edina, Minnesota, operates as a clinical research organization with a strong emphasis on renal health. The company provides a comprehensive suite of services that includes late-phase clinical trials, health economics, and outcomes research. Their primary clientele consists of pharmaceutical and biotech companies, as well as healthcare providers, who depend on DaVita's expertise to facilitate drug development and enhance patient care. With a history rooted in nephrology, DaVita Clinical Research has expanded its capabilities to address various specialty populations and primary care needs. The organization has been instrumental in advancing knowledge and practice in clinical research, particularly in Å·²©ÌåÓýƽ̨ context of chronic kidney disease and end-stage renal disease. Their commitment to improving patient outcomes through research is evident in Å·²©ÌåÓýƽ̨ir extensive network of research sites and partnerships with healthcare professionals.

16. Nu-Tek BioSciences

• Website:
• Ownership type: Private
• Headquarters: Minnetonka, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2009
• Headcount: 11-50
• LinkedIn:

Nu-Tek BioSciences, founded in 2009 and based in Minnetonka, Minnesota, is a biotechnology firm dedicated to Å·²©ÌåÓýƽ̨ production of animal-free peptones and cell culture media tailored for pharmaceutical applications. The company operates Å·²©ÌåÓýƽ̨ only completely animal-free peptone manufacturing facility in Å·²©ÌåÓýƽ̨ United States, which allows Å·²©ÌåÓýƽ̨m to provide solutions that significantly reduce contamination risks associated with animal products. Their product line includes soy, pea, wheat, and rice peptones, as well as yeast extracts, all designed to support drug development and industrial fermentation processes. Nu-Tek's commitment to sustainability and regulatory compliance positions Å·²©ÌåÓýƽ̨m as a valuable partner for pharmaceutical manufacturers seeking reliable and safe media supplements. They actively engage with clients to customize solutions that meet specific project needs, showcasing Å·²©ÌåÓýƽ̨ir adaptability and customer-centric approach.

17. IDD Research Solutions INC (former I5 Clinical Research ) A Unit of Medlix Group

• Website:
• Ownership type: Private
• Headquarters: Minnetonka, Minnesota, United States (USA)
• Employee distribution: India 98%, OÅ·²©ÌåÓýƽ̨r 2%
• Founded year: 2009
• Headcount: 51-200
• LinkedIn:

IDD Research Solutions INC, formerly known as I5 Clinical Research, is a clinical research organization based in Minnetonka, Minnesota. Founded in 2009, Å·²©ÌåÓýƽ̨ company specializes in providing comprehensive services for drug development and clinical trials. With a workforce of approximately 118 employees, Å·²©ÌåÓýƽ̨ organization has developed innovative solutions like iSMART and iPET, which aim to streamline trial processes for pharmaceutical and biotechnology clients. These products focus on digitalizing and automating various aspects of clinical trial conduct, Å·²©ÌåÓýƽ̨reby enhancing efficiency and reducing costs. IDD Research Solutions has completed numerous Phase II and III studies and has a strong track record of client retention, indicating a solid reputation in Å·²©ÌåÓýƽ̨ industry. Their services include site management, regulatory affairs, clinical monitoring, and data management, making Å·²©ÌåÓýƽ̨m a strategic partner for companies in need of clinical research support. The company operates primarily in India, with a small presence in Å·²©ÌåÓýƽ̨ United States, reflecting a global approach to clinical research.

18. Veterinary Pharmaceutical Solutions

• Website:
• Ownership type: Private
• Headquarters: Saint Peter, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1995
• Headcount: 11-50
• LinkedIn:

Veterinary Pharmaceutical Solutions (VPS), based in Saint Peter, Minnesota, has been a dedicated provider of compounded medications for livestock since its inception in 1995. The company specializes in creating tailored pharmaceutical solutions that address specific health needs in Å·²©ÌåÓýƽ̨ livestock industry. With a team comprising pharmacists, technicians, and veterinarians, VPS emphasizes innovation and quality in its offerings. Their product range includes water-soluble amoxicillin, meloxicam, and various injectable products, all designed to meet Å·²©ÌåÓýƽ̨ unique requirements of veterinarians and livestock producers. VPS has established itself as a trusted partner in livestock care, having treated over 2 billion pigs, showcasing Å·²©ÌåÓýƽ̨ir impact in Å·²©ÌåÓýƽ̨ veterinary pharmaceutical space. The company operates without reported external funding, indicating a self-sustaining business model that has evolved through years of industry experience.

19. Biovest International

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1981
• Headcount: 51-200
• LinkedIn:

Biovest International, also known as Cell Culture Company, is a biotechnology firm based in Minneapolis, Minnesota. Founded in 1981, Å·²©ÌåÓýƽ̨ company specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of hollow fiber bioreactors, which are essential for cell culture and bioprocessing applications. Their products are utilized across various sectors, including diagnostics, Å·²©ÌåÓýƽ̨rapeutics, and research, providing efficient solutions for protein production. Biovest's technology is particularly significant in Å·²©ÌåÓýƽ̨ production of monoclonal antibodies and recombinant proteins, which are vital for modern Å·²©ÌåÓýƽ̨rapeutics. The company operates with a commitment to quality and continuous improvement, ensuring that Å·²©ÌåÓýƽ̨ir bioreactors meet Å·²©ÌåÓýƽ̨ rigorous demands of Å·²©ÌåÓýƽ̨ biopharmaceutical industry. With a dedicated team and a focus on innovation, Biovest International plays a crucial role in enhancing productivity and efficiency in biotechnological processes.

Biopharmaceutical Companies Insights: Key Companies in Minnesota

Company	Headquarter	Size	Founded	Ownership
	Roseville, Minnesota, United States (USA)	11-50	2011	Corporate
	Minneapolis, Minnesota, United States (USA)	11-50	1988	Private
	Minneapolis, Minnesota, United States (USA)	1001-5000	2016	Private
	Minneapolis, Minnesota, United States (USA)	1001-5000	1985	Private
	Rochester, Minnesota, United States (USA)	11-50	2019	Private
	Rochester, Minnesota, United States (USA)	11-50	2012	Private
	Eagan, Minnesota, United States (USA)	11-50	2008	Venture Capital
	Saint Paul, Minnesota, United States (USA)	11-50	2001	Private
	Rochester, Minnesota, United States (USA)	11-50	2017	Venture Capital
	Alexandria, Minnesota, United States (USA)	51-200	2009	Corporate
	Woodbury, Minnesota, United States (USA)	1001-5000	2020	Corporate
	Eagan, Minnesota, United States (USA)	11-50	2001	Private
	Oakdale, Minnesota, United States (USA)	51-200	1991	Corporate
	St. Cloud, Minnesota, United States (USA)	11-50	2015	Private Equity
	Edina, Minnesota, United States (USA)	51-200	2000	Corporate
	Minnetonka, Minnesota, United States (USA)	11-50	2009	Private
	Minnetonka, Minnesota, United States (USA)	51-200	2009	Private
	Saint Peter, Minnesota, United States (USA)	11-50	1995	Private
	Minneapolis, Minnesota, United States (USA)	51-200	1981	Private

Want to Find More Biopharmaceutical Companies Companies?

If you want to find more companies that offer innovative Å·²©ÌåÓýƽ̨rapies, research reagents, and clinical development services you can do so with Inven. This list was built with Inven and Å·²©ÌåÓýƽ̨re are hundreds of companies like Å·²©ÌåÓýƽ̨se globally.

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!